Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Details

Justin Kuehn

+1 833-672-0814

justin@kuehn.law

Company Website

https://www.kuehn.law/

View source version on newsdirect.com: https://newsdirect.com/news/kuehn-law-encourages-investors-of-intellia-therapeutics-inc-to-contact-law-firm-739759807

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  273.95
+1.90 (0.70%)
AAPL  284.33
+7.50 (2.71%)
AMD  356.31
+14.76 (4.32%)
BAC  53.34
+1.15 (2.19%)
GOOG  382.76
+3.12 (0.82%)
META  603.41
-7.00 (-1.15%)
MSFT  412.77
-0.85 (-0.21%)
NVDA  196.47
-2.01 (-1.01%)
ORCL  185.90
+5.61 (3.11%)
TSLA  392.23
-0.28 (-0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.